Treatment for Allergic Reaction to Keflex with Only Hives and Itching
Discontinue Keflex immediately and treat with oral second-generation antihistamines as first-line therapy. 1
Immediate Management
Stop the cephalexin (Keflex) right away. The FDA label explicitly states that if an allergic reaction occurs, the drug should be discontinued and the patient treated with usual agents including antihistamines 1. Since the reaction is limited to urticaria (hives) and pruritus (itching) without anaphylaxis, angioedema, or respiratory symptoms, this represents a non-severe, immediate-type allergic reaction.
Symptomatic Treatment
Administer a second-generation antihistamine orally:
- These are the first-line treatment for urticaria and pruritus 2, 3, 4
- Options include: cetirizine, levocetirizine, desloratadine, or fexofenadine
- Standard dosing is typically sufficient initially
- If symptoms persist after 24-48 hours, consider doubling the antihistamine dose, as evidence shows double-dose levocetirizine provides better control of histamine-induced wheal, flare, and itch 5
Monitor the patient closely for progression to more severe symptoms (difficulty breathing, throat swelling, hypotension), though this is unlikely if the reaction has remained limited to skin manifestations 1.
Important Clinical Context
This reaction pattern (isolated hives and itching) does not constitute anaphylaxis. The FDA label distinguishes between simple allergic reactions requiring antihistamines versus "serious acute hypersensitivity reactions" that may require epinephrine, IV fluids, corticosteroids, and airway management 1. Your patient falls into the former category.
Corticosteroids
Systemic corticosteroids are not routinely necessary for isolated urticaria and pruritus from drug reactions. Reserve these for:
- Severe, extensive urticaria not responding to antihistamines
- Signs of progression to more serious reaction
- Persistent symptoms beyond 48-72 hours despite antihistamine therapy
Future Antibiotic Selection
Document this as a cephalexin allergy with specific reaction details (urticaria, pruritus, non-anaphylactic). This is critical for future prescribing decisions.
For future antibiotic needs:
- Cephalosporins with dissimilar R1 side chains can be used safely 6. Cephalexin shares R1 side chains with cefadroxil, cefaclor, and cefprozil—avoid these 7
- Cephalosporins with different side chains (cefazolin, ceftriaxone, cefuroxime, cefpodoxime) have very low cross-reactivity and can be administered directly without skin testing for non-anaphylactic reactions 7, 6
- Penicillins with dissimilar side chains can also be used 6. However, avoid amoxicillin and ampicillin as they share R1 side chains with cephalexin 7
- Carbapenems and aztreonam can be used safely in a clinical setting 6
Key Pitfall to Avoid
Do not label this patient as "allergic to all beta-lactams" or "allergic to all cephalosporins." The 2022 Drug Allergy Practice Parameter emphasizes that cross-reactivity is primarily based on identical R1 side chains, not the beta-lactam ring itself 7. Cross-reactivity between cephalexin and structurally dissimilar cephalosporins is only 2-4%, similar to the rate of new drug allergies in the general population 7.
Skin testing is not indicated for this non-severe reaction when selecting alternative cephalosporins with dissimilar side chains 7. The guidelines reserve skin testing primarily for patients with anaphylactic histories who require parenteral cephalosporins 7.